Tech Company Financing Transactions
Neurolens Funding Round
Neurolens closed a $67 million venture capital round on 9/12/2022. Investors included MVM Life Science Partners, Bluestem Capital and Falcon Vision.
Transaction Overview
Company Name
Announced On
9/12/2022
Transaction Type
Venture Equity
Amount
$67,000,000
Round
Undisclosed
Investors
MVM Life Science Partners (Lead Investor) (Eric Bednarski)
Proceeds Purpose
The company intends to use the funds to continue product innovation and growth initiatives.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1234 Lakeshore Dr 200
Coppell, TX 75019
USA
Coppell, TX 75019
USA
Phone
Website
Email Address
Overview
The NMD2 is an objective, accurate and repeatable way to measure eye alignment. The cutting-edge eye tracking system allows the NMD2 to identify eye misalignment as small as 0.01 Prism Diopters, acquiring over 10,000 data points per patient.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Pierre Bertrand
Chief Operating Officer
Danny Perales
Chief Technical Officer
Aric Plumley
VP - Marketing
Brant Southwell
VP - Operations
Kaelin Currie
Browse more venture capital transactions:
Prev: 9/12/2022: PeopleHedge venture capital transaction
Next: 9/12/2022: Black Diamond Advisory venture capital transaction
Share this article
About Database of VC Transactions
We report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs